New innovations have created massive volumes of never-before-seen data in the Pharmaceutical industry: From smart devices to smart pills and even smart bottles that track usage, this wealth of new data represents immense opportunity. Yet organizations bound by the size and speed limitations of their legacy systems struggle to keep pace.
With a compact and cost-efficient platform, SQream fills the prescription for pharmaceuticals looking to rapidly ingest, analyze, explore, and derive value from their massive influx of data. Researchers can run ad-hoc queries to explore their data on more dimensions. With accelerated analytics feeding the drug-development pipeline, new medications, treatments, and devices can emerge with maximal safety and efficiency.
“SQream is helping us to cut years of cancer research on large genomic datasets.”
Prof. Gideon Rechavi, Head of Cancer Research at Sheba Medical Center